|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/00 | |
| A61P 31/12 |
| (11) | Patento numeris | 2953633 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14748994.2 |
| Europos patento paraiškos padavimo data | 2014-02-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-12-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/014905 |
| Data | 2014-02-05 |
| (87) | Numeris | WO 2014/124028 |
| Data | 2014-08-14 |
| (30) | Numeris | Data | Šalis |
| 201361761133 P | 2013-02-05 | US |
| (72) |
WEISKOPF, Kipp, US
HASENKRUG, Kim J., US
STODDART, Cheryl.A., US
MCCUNE, Joseph M., US
WEISSMAN, Irving L., US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607-5200,
US
The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, 3rd Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US The United States of America, as represented by The Secretary, Department of Health and Human Services, 6011 Executive Boulevard Suite 325, MSC 7660, Bethesda, Maryland 20892-7660, US |
| (54) | CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |
| CD47 TARGETED THERAPIES FOR THE TREATMENT OF INFECTIOUS DISEASE |